Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System). [electronic resource]
Producer: 20110405Description: 2084-9 p. digitalISSN:- 1558-3597
- Aged
- Angioplasty, Balloon, Coronary -- instrumentation
- Coronary Artery Disease -- complications
- Diabetic Angiopathies -- therapy
- Drug-Eluting Stents
- Everolimus
- Female
- Humans
- Immunosuppressive Agents -- administration & dosage
- Male
- Middle Aged
- Paclitaxel -- administration & dosage
- Prospective Studies
- Sirolimus -- administration & dosage
- Treatment Failure
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.